AquaNab is developing precision immunotherapies for aquaculture, initially focusing on sea lice, one of the most persistent challenges facing salmon farming.
AquaNab has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Hamburg, Germany; active in Agritech. Data as of 11 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-08-11 | Other | — |
| Nordic FoodTech VC |
| View deal → |
